These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26178386)

  • 21. Relationship Between Circulating Tumor Cells and Tissue Plasminogen Activator in Patients with Early Breast Cancer.
    Bystricky B; Jurisova S; Karaba M; Minarik G; Benca J; Sedlácková T; Tothova L; Vlkova B; Cierna Z; Janega P; Manasova D; Gronesova P; Pindak D; Mardiak J; Celec P; Mego M
    Anticancer Res; 2017 Apr; 37(4):1787-1791. PubMed ID: 28373442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer.
    Chen J; Ye C; Dong J; Cao S; Hu Y; Situ B; Xi X; Qin S; Xu J; Cai Z; Zheng L; Wang Q
    J Transl Med; 2020 Feb; 18(1):59. PubMed ID: 32028979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating tumor cells in early breast cancer: A connection with vascular invasion.
    Maltoni R; Fici P; Amadori D; Gallerani G; Cocchi C; Zoli M; Rocca A; Cecconetto L; Folli S; Scarpi E; Serra P; Fabbri F
    Cancer Lett; 2015 Oct; 367(1):43-8. PubMed ID: 26184997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of circulating tumor cells in primary and metastatic breast cancer.
    Aurilio G; Sciandivasci A; Munzone E; Sandri MT; Zorzino L; Cassatella MC; Verri E; Rocca MC; Nolè F
    Expert Rev Anticancer Ther; 2012 Feb; 12(2):203-14. PubMed ID: 22316368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
    Krishnamurthy S; Cristofanilli M; Singh B; Reuben J; Gao H; Cohen EN; Andreopoulou E; Hall CS; Lodhi A; Jackson S; Lucci A
    Cancer; 2010 Jul; 116(14):3330-7. PubMed ID: 20564098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden.
    Cristofanilli M; Broglio KR; Guarneri V; Jackson S; Fritsche HA; Islam R; Dawood S; Reuben JM; Kau SW; Lara JM; Krishnamurthy S; Ueno NT; Hortobagyi GN; Valero V
    Clin Breast Cancer; 2007 Feb; 7(6):471-9. PubMed ID: 17386124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal characterization: alternative to simple CTC detection in two clinical trials.
    Barriere G; Riouallon A; Renaudie J; Tartary M; Rigaud M
    Anticancer Res; 2012 Aug; 32(8):3363-9. PubMed ID: 22843916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
    Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
    Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Tumor Cells and Tumor Stem Cells Detection in the Peripheral Blood Mononuclear Cells of Breast Cancer.
    Wang F; Li YC; Liu LP; Zhang HM; Tong S
    J Clin Lab Anal; 2016 Sep; 30(5):616-22. PubMed ID: 26892105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.
    Wülfing P; Borchard J; Buerger H; Heidl S; Zänker KS; Kiesel L; Brandt B
    Clin Cancer Res; 2006 Mar; 12(6):1715-20. PubMed ID: 16551854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of circulating tumor cells in patients with breast cancer using the quantitative RT-PCR assay for monitoring of therapy efficacy.
    Wang HY; Ahn S; Kim S; Park S; Park S; Han H; Sohn JH; Kim S; Lee H
    Exp Mol Pathol; 2014 Dec; 97(3):445-52. PubMed ID: 25217799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrating circulating tumor cell assays into the management of breast cancer.
    Dawood S; Cristofanilli M
    Curr Treat Options Oncol; 2007 Feb; 8(1):89-95. PubMed ID: 17634836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds.
    Menyailo ME; Tretyakova MS; Denisov EV
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
    Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
    J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
    Stojadinovic A; Mittendorf EA; Holmes JP; Amin A; Hueman MT; Ponniah S; Peoples GE
    Ann Surg Oncol; 2007 Dec; 14(12):3359-68. PubMed ID: 17906897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer.
    Gruber I; Landenberger N; Staebler A; Hahn M; Wallwiener D; Fehm T
    Anticancer Res; 2013 May; 33(5):2233-8. PubMed ID: 23645781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumor cells in solid tumor in metastatic and localized stages.
    Maestro LM; Sastre J; Rafael SB; Veganzones SB; Vidaurreta M; Martín M; Olivier C; DE La Orden VB; Garcia-Saenz JA; Alfonso R; Arroyo M; Diaz-Rubio E
    Anticancer Res; 2009 Nov; 29(11):4839-43. PubMed ID: 20032444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.
    Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D
    Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.
    Ejaeidi AA; Craft BS; Puneky LV; Lewis RE; Cruse JM
    Exp Mol Pathol; 2015 Aug; 99(1):163-72. PubMed ID: 26079660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
    Sieuwerts AM; Mostert B; Bolt-de Vries J; Peeters D; de Jongh FE; Stouthard JM; Dirix LY; van Dam PA; Van Galen A; de Weerd V; Kraan J; van der Spoel P; Ramírez-Moreno R; van Deurzen CH; Smid M; Yu JX; Jiang J; Wang Y; Gratama JW; Sleijfer S; Foekens JA; Martens JW
    Clin Cancer Res; 2011 Jun; 17(11):3600-18. PubMed ID: 21505063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.